Multiple Myeloma | Topics

 
FDA Grants Accelerate Approval to Melphalan flufenamide for Heavily Pretreated Myeloma
March 01, 2021

Based on phase 2 data, the FDA granted accelerated approval to melphalan flufenamide in combination with dexamethasone for the treatment of multiple myeloma following 4 or more prior lines of therapy.

KarMMa Trial Results for Ide-Cel in Refractory Myeloma Show Favorable Efficacy
February 25, 2021

Results of a phase 2 trial testing the efficacy of idecabtagene vicleucel in patients with heavily pretreated myeloma are reported.

Previous Cancer Diagnoses Associated with Subsequent Development of Multiple Myeloma
February 10, 2021

Data regarding patients with previous Hodgkin lymphoma and primary myelofibrosis diagnoses found associations with subsequent diagnosis of multiple myeloma.